Steve Cohen Makes Big Purchases in Renewable Energy Group Inc (REGI) and NxStage Medical, Inc. (NXTM)

Page 2 of 2

Among over 700 hedge funds that we track, the interest in Renewable Energy Group Inc (NASDAQ:REGI) slightly decreased during the first quarter to 15 firms having invested about $49.39 million in the company as compared to 16 funds with $76.45 million a quarter earlier. Clint Carlson‘s Carlson Capital has the largest long position in Renewable Energy Group Inc (NASDAQ:REGI) with nearly 4.0 million shares valued at $36.88 million.

Point72’s holding in NxStage Medical, Inc. (NASDAQ:NXTM) comprises 5% of the $1.02 billion healthcare company’s outstanding common stock. Although up by more than 18% over the past year, NxStage Medical, Inc. (NASDAQ:NXTM)’s stock has slid by 10.6% so far this year, despite first quarter revenues exceeding guidance and delivering a 10% increase to $79.5 million on a year-over-year basis, while expected loss in earnings also came in better than anticipated. In contrast, the medical instruments & supplies sector has gained nearly 4.5% during the same time period. The innovative approaches that NxStage Medical, Inc. (NASDAQ:NXTM)’s management aims to derive future growth from include nocturnal therapy,and NxStage Kidney Care, enabling customers to transition to a home hemodialysis.

As far as the hedge fund interest in NxStage Medical, Inc. (NASDAQ:NXTM) is concerned, it increased slightly over the quarter to 21 firms with $173.54 million invested in the company, from 20 funds with $170.48 million in the previous quarter. James E. Flynn‘s Deerfield Management and Justin John Ferayorni‘s Tamarack Capital Management are the two largest stockholders of NxStage Medical, Inc. (NASDAQ:NXTM) in our database with respective stakes of 5.03 million shares and 1.30 million shares.

Disclosure: None

Page 2 of 2